Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-22 4:15 pm Purchase | 2024-10-22 | 13D | Oruka Therapeutics, Inc. ORKA | Adage Capital Management, L.P. | 175,000 0.500% | 175,000 (New Position) | Filing History |
| 2024-06-03 4:30 pm Purchase | 2024-05-31 | 13G | Abeona Therapeutics Inc. ABEO | Adage Capital Management, L.P. | 4,210,429 9.990% | 4,210,429 (New Position) | Filing History |
| 2024-05-01 5:08 pm Unchanged | 2024-04-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Adage Capital Management, L.P. | 5,156,299 9.900% | 0 (Unchanged) | Filing History |
| 2024-04-30 8:53 pm Purchase | 2024-04-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Adage Capital Management, L.P. | 5,156,299 10.350% | 5,156,299 (New Position) | Filing History |
| 2024-04-05 4:05 pm Purchase | 2024-04-03 | 13D | ARCA biopharma, Inc. ABIO | Adage Capital Management, L.P. | 100,000 8.280% | 100,000 (New Position) | Filing History |